19-54970087-C-G
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_017852.5(NLRP2):c.72C>G(p.Ser24Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00113 in 1,614,040 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0062 ( 14 hom., cov: 32)
Exomes 𝑓: 0.00060 ( 10 hom. )
Consequence
NLRP2
NM_017852.5 missense
NM_017852.5 missense
Scores
2
10
Clinical Significance
Conservation
PhyloP100: 0.720
Genes affected
NLRP2 (HGNC:22948): (NLR family pyrin domain containing 2) This gene is a member of the nucleotide-binding and leucine-rich repeat receptor (NLR) family, and is predicted to contain an N-terminal pyrin effector domain (PYD), a centrally-located nucleotide-binding and oligomerization domain (NACHT) and C-terminal leucine-rich repeats (LRR). Members of this gene family are thought to be important regulators of immune responses. This gene product interacts with components of the IkB kinase (IKK) complex, and can regulate both caspase-1 and NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells) activity. The pyrin domain is necessary and sufficient for suppression of NF-kB activity. An allelic variant (rs147585490) has been found that is incapable of blocking the transcriptional activity of NF-kB. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
?
Computational evidence support a benign effect (MetaRNN=0.0044365227).
BP6
?
Variant 19-54970087-C-G is Benign according to our data. Variant chr19-54970087-C-G is described in ClinVar as [Benign]. Clinvar id is 3039591.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
?
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00622 (946/152154) while in subpopulation AFR AF= 0.0217 (899/41520). AF 95% confidence interval is 0.0205. There are 14 homozygotes in gnomad4. There are 453 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
?
High Homozygotes in GnomAd at 14 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NLRP2 | NM_017852.5 | c.72C>G | p.Ser24Arg | missense_variant | 2/13 | ENST00000448584.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NLRP2 | ENST00000448584.7 | c.72C>G | p.Ser24Arg | missense_variant | 2/13 | 1 | NM_017852.5 | P2 |
Frequencies
GnomAD3 genomes ? AF: 0.00622 AC: 946AN: 152036Hom.: 14 Cov.: 32
GnomAD3 genomes
?
AF:
AC:
946
AN:
152036
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00173 AC: 435AN: 251480Hom.: 9 AF XY: 0.00129 AC XY: 176AN XY: 135918
GnomAD3 exomes
AF:
AC:
435
AN:
251480
Hom.:
AF XY:
AC XY:
176
AN XY:
135918
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000595 AC: 870AN: 1461886Hom.: 10 Cov.: 45 AF XY: 0.000513 AC XY: 373AN XY: 727248
GnomAD4 exome
AF:
AC:
870
AN:
1461886
Hom.:
Cov.:
45
AF XY:
AC XY:
373
AN XY:
727248
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.00622 AC: 946AN: 152154Hom.: 14 Cov.: 32 AF XY: 0.00609 AC XY: 453AN XY: 74406
GnomAD4 genome
?
AF:
AC:
946
AN:
152154
Hom.:
Cov.:
32
AF XY:
AC XY:
453
AN XY:
74406
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
92
ESP6500EA
AF:
AC:
2
ExAC
?
AF:
AC:
261
Asia WGS
AF:
AC:
6
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
NLRP2-related disorder Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 14, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
Cadd
Benign
Dann
Uncertain
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationTaster
Benign
N;N;N;N;N;N;N;N
PrimateAI
Benign
T
Sift4G
Uncertain
D;D;D;D;D;D;D;D;T;D
Polyphen
0.94, 0.93
.;.;.;P;P;P;P;P;.;.
Vest4
0.36, 0.40, 0.37, 0.37, 0.38, 0.38
MutPred
Loss of ubiquitination at K25 (P = 0.0603);Loss of ubiquitination at K25 (P = 0.0603);Loss of ubiquitination at K25 (P = 0.0603);Loss of ubiquitination at K25 (P = 0.0603);Loss of ubiquitination at K25 (P = 0.0603);Loss of ubiquitination at K25 (P = 0.0603);Loss of ubiquitination at K25 (P = 0.0603);Loss of ubiquitination at K25 (P = 0.0603);Loss of ubiquitination at K25 (P = 0.0603);Loss of ubiquitination at K25 (P = 0.0603);
MVP
MPC
0.29
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at